ALHC
VENTE TOTALE: 385 270 titres (~4 885 223,60 $ US)
- Insiders
- KAO JOHN E
- Total bought
- —
- Total sold
- $4,885,224
- Last activity
- 2026-09-11
- Last synced
-
2026-09-13 10:23:38
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-12
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 12.4% | 11.0% | 11.0% | 12.8% | 11.0% | |
| Ebit Margin | 0.4% | -3.9% | -7.0% | -9.1% | -15.2% | |
| Ebitda Margin | 1.1% | -2.9% | -5.8% | -7.9% | -13.9% | |
| Operating Profit Margin | 0.4% | -3.8% | -7.0% | -9.0% | -15.2% | |
| Pretax Profit Margin | -0.0% | -4.7% | -8.1% | -10.4% | -16.7% | |
| Continuous Operations Profit Margin | -0.0% | -4.7% | -8.1% | -10.4% | -16.7% | |
| Net Profit Margin | -0.0% | -4.7% | -8.1% | -10.4% | -16.7% | |
| Bottom Line Profit Margin | -0.0% | -4.7% | -8.1% | -10.4% | -16.7% | |
| Current Ratio | 1.709 | 1.880 | 1.838 | 2.368 | 3.306 | |
| Quick Ratio | 1.709 | 1.880 | 1.838 | 2.368 | 3.306 | |
| Solvency Ratio | 0.034 | -0.148 | -0.291 | -0.335 | -0.552 | |
| Cash Ratio | 1.034 | 1.230 | 0.771 | 1.781 | 2.790 | |
| Price To Earnings Ratio | -5,337.838 | -16.791 | -10.899 | -14.169 | -12.333 | |
| Price To Earnings Growth Ratio | 53.675 | 1.105 | 2.261 | 0.521 | -0.015 | |
| Forward Price To Earnings Growth Ratio | 53.675 | 1.105 | 2.261 | 0.521 | -0.015 | |
| Price To Earnings Diluted Ratio | -5,337.838 | -16.791 | -10.899 | -14.169 | -12.333 | |
| Price To Earnings Diluted Growth Ratio | 53.675 | 1.105 | 2.261 | 0.521 | -0.015 | |
| Price To Book Ratio | 21.813 | 21.496 | 10.216 | 8.949 | 7.900 | |
| Price To Sales Ratio | 0.990 | 0.794 | 0.879 | 1.486 | 2.070 | |
| Price To Free Cash Flow Ratio | 34.563 | -322.868 | -16.845 | -30.795 | -24.890 | |
| Price To Operating Cash Flow Ratio | 27.948 | 61.732 | -27.089 | -46.912 | -30.691 | |
| Debt To Assets Ratio | 0.309 | 0.421 | 0.289 | 0.260 | 0.250 | |
| Debt To Equity Ratio | 1.839 | 3.298 | 1.088 | 0.691 | 0.515 | |
| Debt To Capital Ratio | 0.648 | 0.767 | 0.521 | 0.409 | 0.340 | |
| Long Term Debt To Capital Ratio | 0.643 | 0.763 | 0.508 | 0.403 | 0.330 | |
| Financial Leverage Ratio | 5.945 | 7.832 | 3.771 | 2.662 | 2.061 | |
| Working Capital Turnover Ratio | 11.210 | 10.196 | 6.816 | 4.096 | 4.701 | |
| Operating Cash Flow Ratio | 0.251 | 0.099 | -0.225 | -0.198 | -0.471 | |
| Operating Cash Flow Sales Ratio | 0.035 | 0.013 | -0.032 | -0.032 | -0.067 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.809 | -0.191 | 1.608 | 1.523 | 1.233 | |
| Debt Service Coverage Ratio | 2.867 | -3.129 | -4.959 | -6.226 | -9.277 | |
| Interest Coverage Ratio | 0.934 | -4.313 | -6.020 | -7.034 | -10.209 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 28.688 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.424 | 0.106 | -0.347 | -0.276 | -0.500 | |
| Capital Expenditure Coverage Ratio | 5.225 | 0.839 | -1.644 | -1.911 | -4.291 | |
| Dividend Paid And Capex Coverage Ratio | 5.225 | 0.839 | -1.644 | -1.911 | -4.291 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 80.852 | -26.379 | -14.922 | -16.614 | -13.032 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 12.4% | ▲1.4% | ▲0.7% |
| Ebit Margin | 0.4% | ▲4.2% | ▲7.3% |
| Ebitda Margin | 1.1% | ▲4.0% | ▲7.0% |
| Operating Profit Margin | 0.4% | ▲4.1% | ▲7.3% |
| Pretax Profit Margin | -0.0% | ▲4.7% | ▲8.0% |
| Continuous Operations Profit Margin | -0.0% | ▲4.7% | ▲8.0% |
| Net Profit Margin | -0.0% | ▲4.7% | ▲8.0% |
| Bottom Line Profit Margin | -0.0% | ▲4.7% | ▲8.0% |
| Current Ratio | 1.709 | ▼-0.172 | ▼-0.511 |
| Quick Ratio | 1.709 | ▼-0.172 | ▼-0.511 |
| Solvency Ratio | 0.034 | ▲0.182 | ▲0.292 |
| Cash Ratio | 1.034 | ▼-0.196 | ▼-0.487 |
| Price To Earnings Ratio | -5337.838 | ▼-5321.047 | ▼-4259.432 |
| Price To Earnings Growth Ratio | 53.675 | ▲52.569 | ▲42.165 |
| Forward Price To Earnings Growth Ratio | 53.675 | ▲52.569 | ▲42.165 |
| Price To Earnings Diluted Ratio | -5337.838 | ▼-5321.047 | ▼-4259.432 |
| Price To Earnings Diluted Growth Ratio | 53.675 | ▲52.569 | ▲42.165 |
| Price To Book Ratio | 21.813 | ▲0.317 | ▲7.738 |
| Price To Sales Ratio | 0.990 | ▲0.196 | ▼-0.254 |
| Price To Free Cash Flow Ratio | 34.563 | ▲357.431 | ▲106.730 |
| Price To Operating Cash Flow Ratio | 27.948 | ▼-33.785 | ▲30.950 |
| Debt To Assets Ratio | 0.309 | ▼-0.112 | ▲0.004 |
| Debt To Equity Ratio | 1.839 | ▼-1.459 | ▲0.353 |
| Debt To Capital Ratio | 0.648 | ▼-0.120 | ▲0.111 |
| Long Term Debt To Capital Ratio | 0.643 | ▼-0.120 | ▲0.114 |
| Financial Leverage Ratio | 5.945 | ▼-1.887 | ▲1.491 |
| Working Capital Turnover Ratio | 11.210 | ▲1.014 | ▲3.806 |
| Operating Cash Flow Ratio | 0.251 | ▲0.152 | ▲0.360 |
| Operating Cash Flow Sales Ratio | 0.035 | ▲0.023 | ▲0.052 |
| Free Cash Flow Operating Cash Flow Ratio | 0.809 | ▲1.000 | ▼-0.188 |
| Debt Service Coverage Ratio | 2.868 | ▲5.996 | ▲7.012 |
| Interest Coverage Ratio | 0.934 | ▲5.247 | ▲6.262 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | ▼-28.688 | ▼-5.738 |
| Operating Cash Flow Coverage Ratio | 0.424 | ▲0.319 | ▲0.543 |
| Capital Expenditure Coverage Ratio | 5.225 | ▲4.385 | ▲5.581 |
| Dividend Paid And Capex Coverage Ratio | 5.225 | ▲4.385 | ▲5.581 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 80.852 | ▲107.231 | ▲78.871 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $3.91B | $2.15B | $1.60B | $2.13B | $2.42B | |
| Enterprise value | $3.66B | $2.04B | $1.57B | $1.89B | $2.11B | |
| EV / Sales | 0.93x | 0.76x | 0.86x | 1.31x | 1.81x | |
| EV / Op. cash flow | 26.19x | 58.75x | -26.55x | -41.52x | -26.77x | |
| EV / Free cash flow | 32.39x | -307.29x | -16.51x | -27.26x | -21.71x | |
| EV / EBITDA | 80.85x | -26.38x | -14.92x | -16.61x | -13.03x | |
| Net debt / EBITDA | -5.43x | 1.34x | 0.30x | 2.16x | 1.91x | |
| Current ratio | 1.71x | 1.88x | 1.84x | 2.37x | 3.31x | |
| Income quality | -143.07x | -0.27x | 0.40x | 0.30x | 0.40x | |
| Graham net-net | -$0 | -$0 | -$0 | $0 | $1 | |
| Tax burden | 75.6% | 100.0% | 99.9% | 100.2% | 100.0% | |
| Interest burden | -6.5% | 122.5% | 116.7% | 114.0% | 109.8% | |
| Working capital | $394.7M | $309.8M | $220.5M | $314.6M | $385.6M | |
| Invested capital | $502.6M | $424.1M | $322.5M | $397.9M | $458.9M | |
| Return on assets | -0.1% | -16.4% | -25.0% | -23.6% | -31.0% | |
| Operating ROA | 1.6% | -14.8% | -20.9% | -20.3% | -36.7% | |
| Return on tangible assets | -0.1% | -17.2% | -26.8% | -25.2% | -32.8% | |
| Return on equity | -0.4% | -128.2% | -94.3% | -62.8% | -63.8% | |
| Return on invested capital | 2.9% | -23.5% | -38.9% | -31.8% | -38.4% | |
| Return on capital employed | 2.9% | -23.6% | -38.9% | -31.8% | -38.4% | |
| Earnings yield | -0.0% | -6.0% | -9.2% | -7.0% | -8.1% | |
| Free cash flow yield | 2.9% | -0.3% | -5.9% | -3.2% | -4.0% | |
| Capex / Op. cash flow | 19.1% | 119.1% | -60.8% | -52.3% | -23.3% | |
| Capex / Depreciation | 87.9% | 153.0% | 166.1% | 136.0% | 114.5% | |
| Capex / Sales | 0.7% | 1.5% | 2.0% | 1.7% | 1.6% | |
| SG&A / Sales | 0.0% | 13.7% | 16.9% | 20.6% | 24.9% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.6% | 2.6% | 3.7% | 5.7% | 9.5% | |
| Intangibles / Total assets | 3.4% | 5.0% | 6.8% | 6.4% | 5.6% | |
| Days sales outstanding | 23d | 21d | 24d | 24d | 18d | |
| Days payables outstanding | 44d | 37d | 38d | 50d | 6d | |
| Operating cycle | 23d | 21d | 24d | 24d | 18d | |
| Cash conversion cycle | -20d | -16d | -14d | -27d | 12d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+82.2%EV / Sales ▲+22.8%EV / EBITDA ▲+406.5%EV / Op. cash flow ▼-32.564Earnings yield ▲+0.059
Profitability
Return on equity ▲+1.278Return on assets ▲+0.163Return on invested capital ▲+0.264Return on capital employed ▲+0.265Operating ROA ▲+0.164Income quality ▼-142.803Tax burden ▼-0.244
Efficiency
Days sales outstanding ▲+2.627Days payables outstanding ▲+7.080Operating cycle ▲+2.627Cash conversion cycle ▼-4.453Capex / Sales ▼-0.009R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.172Net debt / EBITDA ▼-6.769Working capital ▲+84918000.000Invested capital ▲+78465000.000Intangibles / Total assets ▼-0.016
Change over 5 years
Valuation
Market cap ▲+61.7%EV / Sales ▼-48.6%EV / EBITDA ▲+720.4%EV / Op. cash flow ▲+52.957Earnings yield ▲+0.081
Profitability
Return on equity ▲+0.634Return on assets ▲+0.309Return on invested capital ▲+0.413Return on capital employed ▲+0.413Operating ROA ▲+0.383Income quality ▼-143.478Tax burden ▼-0.244
Efficiency
Days sales outstanding ▲+5.117Days payables outstanding ▲+37.731Operating cycle ▲+5.117Cash conversion cycle ▼-32.615Capex / Sales ▼-0.009R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-1.597Net debt / EBITDA ▼-7.341Working capital ▲+9097000.000Invested capital ▲+43650000.000Intangibles / Total assets ▼-0.021
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-09-10 Alignment Health''s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt
- 2026-09-09 Kaplan Fox Reminds Alignment Healthcare, Inc. (ALHC) Investors of an Investigation into Potential Securities Law Violations New York, New York--(Newsfile Corp. - September 9, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.
- 2026-09-09 Kaplan Fox Reminds Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Protect Their Rights Amid a Securities Investigation NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
- 2026-09-08 Kaplan Fox & Kilsheimer LLP Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.
- 2026-09-08 Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors Expanded provider relationship increases access to Hoag physicians, hospitals and specialty programs beginning Jan. 1, 2027 Expanded provider relationship increases access to Hoag physicians, hospitals and specialty programs beginning Jan. 1, 2027
- 2026-09-04 Kaplan Fox is Investigating Alignment Healthcare, Inc. (ALHC) on Behalf of Investors for Potential Securities Law Violations New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.
- 2026-09-04 Kaplan Fox Continues its Investigation of Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (NASDAQ: ALHC).
- 2026-09-04 Jupiter Topco LLC Acquires New Holdings in Alignment Healthcare, Inc. $ALHC Jupiter Topco LLC bought a new stake in Alignment Healthcare, Inc. (NASDAQ: ALHC) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 79,155 shares of the company''s stock, valued at approximately $1,885,000. Other hedge funds also recently bought and
- 2026-09-03 Kaplan Fox is Investigating Alignment Healthcare, Inc. (ALHC) and Encourages Investors Who Suffered Losses to Contact the Firm New York, New York--(Newsfile Corp. - September 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.
- 2026-09-02 Kaplan Fox & Kilsheimer LLP Announces an Investigation into Alignment Healthcare, Inc. (ALHC) for Possible Securities Law Violations New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.